303 related articles for article (PubMed ID: 10225967)
1. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
Abrams JR; Lebwohl MG; Guzzo CA; Jegasothy BV; Goldfarb MT; Goffe BS; Menter A; Lowe NJ; Krueger G; Brown MJ; Weiner RS; Birkhofer MJ; Warner GL; Berry KK; Linsley PS; Krueger JG; Ochs HD; Kelley SL; Kang S
J Clin Invest; 1999 May; 103(9):1243-52. PubMed ID: 10225967
[TBL] [Abstract][Full Text] [Related]
2. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
[TBL] [Abstract][Full Text] [Related]
3. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
4. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
Onodera K; Chandraker A; Schaub M; Stadlbauer TH; Korom S; Peach R; Linsley PS; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 1997 Aug; 159(4):1711-7. PubMed ID: 9257832
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
McIntosh KR; Linsley PS; Drachman DB
Cell Immunol; 1995 Nov; 166(1):103-12. PubMed ID: 7585970
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
Quattrocchi E; Dallman MJ; Feldmann M
Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858
[TBL] [Abstract][Full Text] [Related]
7. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
8. Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7.
Nestle FO; Thompson C; Shimizu Y; Turka LA; Nickoloff BJ
Cell Immunol; 1994 Jun; 156(1):220-9. PubMed ID: 7515331
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
[TBL] [Abstract][Full Text] [Related]
10. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
12. Is CTLA-4 a master switch for peripheral T cell tolerance?
Bluestone JA
J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
[TBL] [Abstract][Full Text] [Related]
13. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
14. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
Ding L; Shevach EM
Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
16. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
17. Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis.
Matsui Y; Inobe M; Okamoto H; Chiba S; Shimizu T; Kitabatake A; Uede T
J Mol Cell Cardiol; 2002 Mar; 34(3):279-95. PubMed ID: 11945021
[TBL] [Abstract][Full Text] [Related]
18. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
19. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
Bossowski A; Stasiak-Barmuta A; Urban M
Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
[TBL] [Abstract][Full Text] [Related]
20. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
